Psychometric Properties of the Hangover Symptoms Scale (Hss)

Pombo, Samuel; Marinho, Ângelo; Sampaio, Daniel

doi:10.15309/19psd200303

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Additional instruments used in the study included as follows: HADS (Hospital Anxiety and Depression Scale): a scale with 7‐item subscales that measure recent depression (HADS‐D) and anxiety (HADS‐A) levels, translated to the Portuguese language (Pais‐Ribeiro et al., 2007; Zigmond & Snaith, 1983). PACS (the Penn Alcohol Craving Scale): a validated scale in Portuguese to assess alcohol craving levels (Flannery et al., 1999; Pombo et al., 2008). CIWA‐Ar (Clinical Institute Withdrawal Assessment for Alcohol‐Revised): to evaluate withdrawal symptoms from alcohol (Sullivan et al., 1989).…”

Section: Methodsmentioning

confidence: 99%

Predicting alcohol relapse post‐detoxification: The role of cognitive impairments in alcohol use disorder patients

Teixeira,

Pinheiro,

Pereira

et al. 2024

Alcohol, Clinical and Experimental Research

View full text Add to dashboard Cite

BackgroundStudies on early abstinence suggest that cognitive function is significantly reduced in the first year of abstinence, which raises the question of whether it is relevant to early relapse in patients with substance use disorders. This study investigates the extent to which impairments in executive function and memory predict alcohol relapse in patients with alcohol use disorder (AUD). Understanding these relationships is crucial for improving therapeutic approaches to prevent relapse in patients with AUD.MethodsWe selected 116 adult patients (79 male and 37 female) diagnosed with AUD based on DSM‐5 criteria, all of whom were undergoing alcohol detoxification treatment. A comprehensive array of neuropsychological tests was administered to assess global cognition, memory, and executive functions. Patients' alcohol use was monitored monthly during a 6‐month follow‐up period. Logistic regression and Cox regression were used to explore the relationship between cognitive function and the likelihood of alcohol relapse.ResultsImpairments in global cognition, semantic and phonemic fluency, cognitive flexibility, and learning ability during detoxification were significant predictors of relapse in AUD patients, showing similar predictive values at both 3 and 6 months post‐treatment. An abnormal Montreal Cognitive Assessment (MoCA) score increased the risk of relapse by 123% (HR: 2.227), and impairments in both semantic and phonemic fluency each increased the risk by 142% (HR: 2.423). Additionally, abnormal performance on the MoCA, Trail Making Test Part B (TMT‐B), and California Verbal Learning Test (CVLT) was associated with a higher number of drinking days at 3 months (IRR: 3.764; IRR: 2.237; IRR: 2.738, respectively) and abnormal MoCA and TMT‐B scores at 6 months (IRR: 2.451; IRR: 1.859, respectively).ConclusionsThe MoCA test is a valuable tool for predicting relapse risk in AUD patients undergoing detoxification treatment, with similar predictive value for relapse at 3 or 6 months. Learning ability needs to be assessed and their impairments considered in the treatment of AUD patients. Future research should explore strategies for managing patients with impairments in memory and learning ability to enhance treatment effectiveness and prevent relapse.

show abstract